Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized-Withdrawal, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Subjects With Behcet's Disease Uveitis

NCT02258867 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT02258867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02258867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized-Withdrawal, Double-Masked, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Subjects With Behcet's Disease Uveitis
Lead sponsor
XOMA (US) LLC
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2014
Completion date
November 30, 2015
Enrollment
4 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

behcet's disease uveitis